Evotec SE (EUR)
EVT
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range21.13 | 21.35
52-Wk Range |
Last Close-
Mkt Cap (m)-
Dividend yield-
ISINDE0005664809
Volume-
Exchange VenueETR

Company Profile

Evotec AG is a drug discovery and development company. It provides integrated drug discovery services and alliances to the pharmaceutical and biotechnology industry.

Key Information
Price/Earning-
Price/Book-
Price/Sales-
P/CF-
Rev Growth (3 year avg)43.26
EPS Growth (3 year avg)0.67
Operating Margin % 16.73
Net Margin %22.42
Return on Equity22.30
Debt/Equity0.27

Legal Documents

Annual Report
en 31/12/2016

Financials

Income Statement
EUR201320142015201620172018
Revenue (m)8689128165258375
Operating Income (m)42-3373963
Net Income (m)-25-717282484
Basic EPS-0.21-0.050.130.200.170.57
Avg. Diluted Shares Outstanding (m)121131138133152150
Balance Sheet
EUR201320142015201620172018
Current Assets (m)123125167169180250
Non Current Assets (m)10599122182487522
Total Assets (m)227225289351667772
Current Liabilities (m)39335673246196
Total Liabilities (m)------
Total Equity (m)159158186213331424
Cash Flows
EUR201320142015201620172018
Operating Cash Flows (m)7-4166711156
Capital Expenditure (m)-5-5-11-10-18-28
Figures are quoted in EUR unless stated otherwise
21.34
Last Price